Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention

Table 2 Clinical and laboratory findings at baseline and follow-up

	Baseline			Follow-up
	Event (+) (n = 40)	Event (−) (n = 200)	P value	Event (+) (n = 40)	Event (−) (n = 200)	P value
Systolic blood pressure (mmHg)	148 ± 26	143 ± 21	0.20	147 ± 25	142 ± 23	0.22
Diastolic blood pressure (mmHg)	82 ± 14	79 ± 13	0.15	82 ± 13	79 ± 14	0.23
HDL cholesterol (mg/dl)	45 ± 10	44 ± 12	0.75	49 ± 14	46 ± 13	0.19
LDL cholesterol (mg/dl)	96 ± 30	90 ± 23	0.17	84 ± 25	84 ± 20	0.98
Triglyceride (mg/dl)	137 ± 55	127 ± 61	0.34	124 ± 86	119 ± 57	0.66
Creatinine (mg/dl)	0.79 ± 0.17	0.79 ± 0.20	0.82	0.83 ± 0.21	0.80 ± 0.21	0.36
Hs-CRP (mg/L), median (25th–75th)	0.08 (0.04–0.15)	0.08 (0.03–0.22)	0.75	0.05 (0.03–0.13)	0.07 (0.03–0.17)	0.65
BNP (pg/ml), median (25th–75th)	34 (23–62)	30 (14–68)	0.28	28 (14–77)	30 (15–56)	0.90

Data are presented as mean ± SD
HDL high-density lipoprotein, LDL low-density lipoprotein, CRP C-reactive protein, BNP brain natriuretic peptide

ISSN: 1475-2840